Skip to content

RNF10 deficiency in cardiomyocytes impairs mitophagy and drives pathological hypertrophy.

Jul 2026 · Acta Pharmacologica Sinica · 0 citations · 35 references
Medicine

TL;DR

This study identifies RNF10 as a critical regulator of cardiac mitophagy, suggesting that targeting cardiac RNF10 may represent a therapeutic strategy for treating cardiac pathologies.

View source

Similar papers

Open access Aug 2026

Loss of Miro1 drives cardiac and mitochondrial dysfunction exacerbated by metabolic stress.

A cardiac-specific Miro1 knockout mouse model is generated to investigate how cardiomyocyte-Miro1 deficiency affects cardiac and mitochondrial structure-function and identifies Miro1 as a regulator of mitochondrial morphology.

Sarah Kassab, Zainab Albalawi, Asim M Khojah et al. · 0 citations
Open access Aug 2026

Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination

Pathological cardiac hypertrophy is maladaptive cardiac remodeling induced by chronic adverse stimuli. In this study, the E3 ubiquitin ligase RNF128 was identified as a suppressor of pathological cardiac dysfunction with therapeutic value. Methods The expression of Ring Finger protein 128 (RNF128) in pathological cardi...

Yu-Jie Zhang, Xuehan Liu, Li-Wen Yu et al. · 0 citations
Sep 2026

Claudin-5 regulates mitochondrial bioenergetics and protects the heart against myocardial infarction.

Claudin-5 (Cldn5) is traditionally recognized as a key component of endothelial tight junctions, however, its potential intracellular function within cardiomyocytes remains largely unexplored. This study aims to explore the molecular mechanisms underlying the cardioprotective role of Cldn5 on myocardial infarction (MI)...

Xia Yu, Bai-He Chen, Li-Jun Wang et al. · 0 citations
Open access Aug 2026

Myocilin drives cardiomyocyte mitochondrial dysfunction via SLC3A2-dependent redox imbalance in heart failure

Heart failure (HF) remains a leading cause of morbidity and mortality worldwide. A hallmark of HF progression is profound metabolic remodeling accompanied by mitochondrial dysfunction in cardiomyocytes. Impaired mitochondrial oxidative phosphorylation, excessive reactive oxygen species (ROS) production, and disrupted r...

Xiaoyue Yu, Junxia Zhang, Jun-Fang Wu et al. · 0 citations
Open access Aug 2026

Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function

Background: Protein quality control (PQC) is critical for maintaining sarcomere structure and function in cardiomyocytes. Mutations in PQC pathway proteins, namely CRYAB-R120G (arginine to glycine at position 120) and BAG3-P209L (proline to lysine at position 209) induce protein aggregates and cardiomyopathy in humans....

David R. Rawnsley, Moydul Islam, Chen Zhao et al. · 0 citations
Sep 2026

Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.

BACKGROUND Heart failure remains a leading cause of mortality globally, driven by persistent mitochondrial dysfunction and maladaptive cardiac hypertrophy. Although impaired autophagic flux contributes to cardiac deterioration, the precise molecular mechanisms are still unclear. The ubiquitin-proteasome system serves a...

Yi-Cheng Lv, Zhao Sha, Shi Peng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.